Trademark: 79347676
Word
SHIELDED-CELL & IMMUNOTHERAPY PAIRS
Status Date
Monday, October 23, 2023
Filing Date
Monday, July 4, 2022
Abandoned Date
Tuesday, October 10, 2023
5 Pharmaceutical products for gene and cell therapy
44 Gene and cell therapy services; consultant services in the fields of gene therapy and cell therapy
42 Pharmaceutical research and development services in the fields of gene therapy and cell therapy; medical and pharmaceutical research and development services, all in the fields of gene therapy and cell therapy; research services relating to pharmaceutical products for gene and cell therapy; biochemistry research services relating to cell therapy and gene therapy
SHIELDED CELL AND IMMUNOTHERAPY PAIRS
Feb 13, 2024
Notification Of Possible Opposition - Processed By Ib
Jan 24, 2024
Notification Of Possible Opposition Sent To Ib
Jan 24, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Oct 23, 2023
Abandonment Notice Mailed - Failure To Respond
Oct 23, 2023
Abandonment Notice Mailed - Failure To Respond
Oct 23, 2023
Abandonment - Failure To Respond Or Late Response
May 2, 2023
Refusal Processed By Ib
Apr 6, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Apr 6, 2023
Refusal Processed By Mpu
Feb 18, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Feb 17, 2023
Non-Final Action Written
Feb 10, 2023
Assigned To Examiner
Aug 23, 2022
Application Filing Receipt Mailed
Aug 19, 2022
New Application Office Supplied Data Entered
Aug 18, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
